Samarium Sm-153 lexidronam pentasodium
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Samarium Sm-153 lexidronam pentasodium, covering 2018-08-14 to 2018-08-14. Get the full timeline:
Most recent: Clinical Trial Update: Samarium Sm 153 Lexidronam Pentasodium Combined With Zoledronic Acid or Pamidronate in Treating Patients With Relapsed or Refractory Multiple Myeloma and Bone Pain [Phase 1, Phase 2]